Company Filing History:
Years Active: 2019-2024
Title: Emily P Thi: Innovator in Therapeutic Nucleic Acids
Introduction
Emily P Thi is a prominent inventor based in Coquitlam, Canada. She has made significant contributions to the field of therapeutic nucleic acids, holding a total of 3 patents. Her work focuses on developing targeted compositions that can effectively treat liver diseases.
Latest Patents
Emily's latest patents include innovative nucleic acids, specifically double-stranded siRNA molecules. These inventions provide conjugates that comprise a targeting moiety, a double-stranded siRNA, and optional linking groups. The synthetic methods she developed are useful for preparing these conjugates, which are designed to target therapeutic double-stranded siRNA to the liver. This approach aims to treat liver diseases, including hepatitis B and hepatitis D.
Career Highlights
Emily P Thi is associated with Arbutus Biopharma Corporation, where she continues to advance her research in the field of biopharmaceuticals. Her work has garnered attention for its potential impact on treating serious liver conditions.
Collaborations
Some of her notable coworkers include Amy C H Lee and Nicholas Michael Snead. Their collaborative efforts contribute to the innovative research environment at Arbutus Biopharma Corporation.
Conclusion
Emily P Thi is a trailblazer in the development of targeted therapeutic compositions, with a focus on liver diseases. Her contributions to the field are paving the way for new treatment options and improving patient outcomes.